Assessment of NSAID-treated patients adherence to co-prescribed Proton Pump Inhibitor (PPI) - CONVOY
Study identifier:NIS-RSE-ATC-2011/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Cross-sectional, observational Real Life study on NSAIDs treated patients with Osteoarthritis, Rheumatoid Arthritis and Ankylosing Spondylitis: Assessment of patient adherence to PPI treatment
Medical condition
Osteoarthritis, Rheumatoid Arthritis
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
102
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Mar 2012
Primary Completion Date: 01 May 2012
Study Completion Date: 01 May 2012
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Patients with Osteoarthritis, Rheumatoid Arthritis and Ankylosing Spondylitis, 18 years or older | - |
Contacts
Investigators
Principal Investigator
Georgios Stratelis
AstraZeneca Nordics, B674:4 151 87 Södertälje, Sweden
